Cargando…
Use of topical versus injectable anaesthesia for ShangRing circumcisions in men and boys in Kenya: Results from a randomized controlled trial
BACKGROUND: The ShangRing is a disposable, collar clamp circumcision device pre-qualified for use in men and boys 13 years and above. It has been shown to be faster than conventional circumcision with comparable adverse event (AE) rates and high client satisfaction. Voluntary medical male circumcisi...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6693766/ https://www.ncbi.nlm.nih.gov/pubmed/31412032 http://dx.doi.org/10.1371/journal.pone.0218066 |
_version_ | 1783443734761832448 |
---|---|
author | Awori, Quentin Li, Philip S. Lee, Richard K. Ouma, Daniel Oundo, Millicent Barasa, Mukhaye Obura, Nereah Mwamkita, David Simba, Raymond Oketch, Jairus Nyangweso, Nixon Maina, Mary Kiswi, Nicholas Kirui, Michael Chirchir, Betty Goldstein, Marc Barone, Mark A. |
author_facet | Awori, Quentin Li, Philip S. Lee, Richard K. Ouma, Daniel Oundo, Millicent Barasa, Mukhaye Obura, Nereah Mwamkita, David Simba, Raymond Oketch, Jairus Nyangweso, Nixon Maina, Mary Kiswi, Nicholas Kirui, Michael Chirchir, Betty Goldstein, Marc Barone, Mark A. |
author_sort | Awori, Quentin |
collection | PubMed |
description | BACKGROUND: The ShangRing is a disposable, collar clamp circumcision device pre-qualified for use in men and boys 13 years and above. It has been shown to be faster than conventional circumcision with comparable adverse event (AE) rates and high client satisfaction. Voluntary medical male circumcision (VMMC) has been shown to dramatically reduce the risk of HIV acquisition in males. However, the fear of pain during circumcision is an important barrier to uptake. Use of topical anesthesia thus presents an opportunity to address this. OBJECTIVES: We sought to evaluate the safety, effectiveness and acceptability of the use of topical anaesthesia with ShangRing circumcision of men and boys 10 years of age and above. METHODS: Participants were randomised 2:1 to receive topical or injectable anaesthesia. All participants underwent no-flip ShangRing circumcision. The primary outcome measure was pain. Secondary outcomes included ease of use of topical versus injectable anaesthesia, AEs and participant satisfaction. RESULTS: Compared to the topical group, participants in the injectable group reported significantly more pain on administration of the anesthesia and at approximately 20 minutes after the procedure. In the topical group, sufficient anaesthesia with topical cream was not achieved in 21 (9.3%) cases before the start of the procedure; in another 6 (2.6%), supplementary injectable anaesthesia was required as the circumcision was being carried out. The AE rate was significantly lower (p<0.01) in the topical (0%) vs. the injectable group (4.2%). The most common AE was pain during the post-operative period. All AEs were managed conservatively and resolved without sequeale. 96.7% of participants were satisfied with the appearance of the healed penis and 100% would recommend the ShangRing to others. All seven male circumcision providers involved in the study preferred topical to injectable anaesthesia. CONCLUSIONS: Our results demonstrate the safety, improved clinical experience, effectiveness, and acceptability of the use of topical anaesthesia in ShangRing circumcision using the no-flip technique. Topical anaesthesia effectively eliminates needlestick pain from the clients’ VMMC experience and thus has the potential to increase demand for the service. TRIAL REGISTRATION: ClinicalTrials.gov NCT02390310. |
format | Online Article Text |
id | pubmed-6693766 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-66937662019-08-16 Use of topical versus injectable anaesthesia for ShangRing circumcisions in men and boys in Kenya: Results from a randomized controlled trial Awori, Quentin Li, Philip S. Lee, Richard K. Ouma, Daniel Oundo, Millicent Barasa, Mukhaye Obura, Nereah Mwamkita, David Simba, Raymond Oketch, Jairus Nyangweso, Nixon Maina, Mary Kiswi, Nicholas Kirui, Michael Chirchir, Betty Goldstein, Marc Barone, Mark A. PLoS One Research Article BACKGROUND: The ShangRing is a disposable, collar clamp circumcision device pre-qualified for use in men and boys 13 years and above. It has been shown to be faster than conventional circumcision with comparable adverse event (AE) rates and high client satisfaction. Voluntary medical male circumcision (VMMC) has been shown to dramatically reduce the risk of HIV acquisition in males. However, the fear of pain during circumcision is an important barrier to uptake. Use of topical anesthesia thus presents an opportunity to address this. OBJECTIVES: We sought to evaluate the safety, effectiveness and acceptability of the use of topical anaesthesia with ShangRing circumcision of men and boys 10 years of age and above. METHODS: Participants were randomised 2:1 to receive topical or injectable anaesthesia. All participants underwent no-flip ShangRing circumcision. The primary outcome measure was pain. Secondary outcomes included ease of use of topical versus injectable anaesthesia, AEs and participant satisfaction. RESULTS: Compared to the topical group, participants in the injectable group reported significantly more pain on administration of the anesthesia and at approximately 20 minutes after the procedure. In the topical group, sufficient anaesthesia with topical cream was not achieved in 21 (9.3%) cases before the start of the procedure; in another 6 (2.6%), supplementary injectable anaesthesia was required as the circumcision was being carried out. The AE rate was significantly lower (p<0.01) in the topical (0%) vs. the injectable group (4.2%). The most common AE was pain during the post-operative period. All AEs were managed conservatively and resolved without sequeale. 96.7% of participants were satisfied with the appearance of the healed penis and 100% would recommend the ShangRing to others. All seven male circumcision providers involved in the study preferred topical to injectable anaesthesia. CONCLUSIONS: Our results demonstrate the safety, improved clinical experience, effectiveness, and acceptability of the use of topical anaesthesia in ShangRing circumcision using the no-flip technique. Topical anaesthesia effectively eliminates needlestick pain from the clients’ VMMC experience and thus has the potential to increase demand for the service. TRIAL REGISTRATION: ClinicalTrials.gov NCT02390310. Public Library of Science 2019-08-14 /pmc/articles/PMC6693766/ /pubmed/31412032 http://dx.doi.org/10.1371/journal.pone.0218066 Text en © 2019 Awori et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Awori, Quentin Li, Philip S. Lee, Richard K. Ouma, Daniel Oundo, Millicent Barasa, Mukhaye Obura, Nereah Mwamkita, David Simba, Raymond Oketch, Jairus Nyangweso, Nixon Maina, Mary Kiswi, Nicholas Kirui, Michael Chirchir, Betty Goldstein, Marc Barone, Mark A. Use of topical versus injectable anaesthesia for ShangRing circumcisions in men and boys in Kenya: Results from a randomized controlled trial |
title | Use of topical versus injectable anaesthesia for ShangRing circumcisions in men and boys in Kenya: Results from a randomized controlled trial |
title_full | Use of topical versus injectable anaesthesia for ShangRing circumcisions in men and boys in Kenya: Results from a randomized controlled trial |
title_fullStr | Use of topical versus injectable anaesthesia for ShangRing circumcisions in men and boys in Kenya: Results from a randomized controlled trial |
title_full_unstemmed | Use of topical versus injectable anaesthesia for ShangRing circumcisions in men and boys in Kenya: Results from a randomized controlled trial |
title_short | Use of topical versus injectable anaesthesia for ShangRing circumcisions in men and boys in Kenya: Results from a randomized controlled trial |
title_sort | use of topical versus injectable anaesthesia for shangring circumcisions in men and boys in kenya: results from a randomized controlled trial |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6693766/ https://www.ncbi.nlm.nih.gov/pubmed/31412032 http://dx.doi.org/10.1371/journal.pone.0218066 |
work_keys_str_mv | AT aworiquentin useoftopicalversusinjectableanaesthesiaforshangringcircumcisionsinmenandboysinkenyaresultsfromarandomizedcontrolledtrial AT liphilips useoftopicalversusinjectableanaesthesiaforshangringcircumcisionsinmenandboysinkenyaresultsfromarandomizedcontrolledtrial AT leerichardk useoftopicalversusinjectableanaesthesiaforshangringcircumcisionsinmenandboysinkenyaresultsfromarandomizedcontrolledtrial AT oumadaniel useoftopicalversusinjectableanaesthesiaforshangringcircumcisionsinmenandboysinkenyaresultsfromarandomizedcontrolledtrial AT oundomillicent useoftopicalversusinjectableanaesthesiaforshangringcircumcisionsinmenandboysinkenyaresultsfromarandomizedcontrolledtrial AT barasamukhaye useoftopicalversusinjectableanaesthesiaforshangringcircumcisionsinmenandboysinkenyaresultsfromarandomizedcontrolledtrial AT oburanereah useoftopicalversusinjectableanaesthesiaforshangringcircumcisionsinmenandboysinkenyaresultsfromarandomizedcontrolledtrial AT mwamkitadavid useoftopicalversusinjectableanaesthesiaforshangringcircumcisionsinmenandboysinkenyaresultsfromarandomizedcontrolledtrial AT simbaraymond useoftopicalversusinjectableanaesthesiaforshangringcircumcisionsinmenandboysinkenyaresultsfromarandomizedcontrolledtrial AT oketchjairus useoftopicalversusinjectableanaesthesiaforshangringcircumcisionsinmenandboysinkenyaresultsfromarandomizedcontrolledtrial AT nyangwesonixon useoftopicalversusinjectableanaesthesiaforshangringcircumcisionsinmenandboysinkenyaresultsfromarandomizedcontrolledtrial AT mainamary useoftopicalversusinjectableanaesthesiaforshangringcircumcisionsinmenandboysinkenyaresultsfromarandomizedcontrolledtrial AT kiswinicholas useoftopicalversusinjectableanaesthesiaforshangringcircumcisionsinmenandboysinkenyaresultsfromarandomizedcontrolledtrial AT kiruimichael useoftopicalversusinjectableanaesthesiaforshangringcircumcisionsinmenandboysinkenyaresultsfromarandomizedcontrolledtrial AT chirchirbetty useoftopicalversusinjectableanaesthesiaforshangringcircumcisionsinmenandboysinkenyaresultsfromarandomizedcontrolledtrial AT goldsteinmarc useoftopicalversusinjectableanaesthesiaforshangringcircumcisionsinmenandboysinkenyaresultsfromarandomizedcontrolledtrial AT baronemarka useoftopicalversusinjectableanaesthesiaforshangringcircumcisionsinmenandboysinkenyaresultsfromarandomizedcontrolledtrial |